Filtros : "Clinical Therapeutics" Removido: "FARMACOCINÉTICA" Limpar

Filtros



Limitar por data


  • Fonte: Clinical Therapeutics. Unidades: FOB, FMRP

    Assuntos: FÁRMACOS, ANTIDEPRESSIVOS, HEMORRAGIA, SISTEMA GASTROINTESTINAL

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FORGERINI, Marcela et al. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study. Clinical Therapeutics, v. 45, n. 7, p. e159-e166, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2023.04.010. Acesso em: 27 jun. 2025.
    • APA

      Forgerini, M., Schiavo, G., Urbano, G., Nadai, T. R. de, Zapata-Cachafeiro, M., Herdeiro, M. T. F., & Mastroianni, P. de C. (2023). Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study. Clinical Therapeutics, 45( 7), e159-e166. doi:10.1016/j.clinthera.2023.04.010
    • NLM

      Forgerini M, Schiavo G, Urbano G, Nadai TR de, Zapata-Cachafeiro M, Herdeiro MTF, Mastroianni P de C. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study [Internet]. Clinical Therapeutics. 2023 ; 45( 7): e159-e166.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2023.04.010
    • Vancouver

      Forgerini M, Schiavo G, Urbano G, Nadai TR de, Zapata-Cachafeiro M, Herdeiro MTF, Mastroianni P de C. Use of antidepressants and the risk of upper gastrointestinal tract bleeding: a case-control study [Internet]. Clinical Therapeutics. 2023 ; 45( 7): e159-e166.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2023.04.010
  • Fonte: Clinical Therapeutics. Unidade: FMRP

    Assuntos: GLAUCOMA, HIPERTENSÃO OCULAR, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELFORT JUNIOR, Rubens et al. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil. Clinical Therapeutics, v. 42, n. 2, p. 263-275, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2019.12.008. Acesso em: 27 jun. 2025.
    • APA

      Belfort Junior, R., Paula, J. S., Silva, M. J. L., Della Paolera, M., Kim, T., Chen, M. Y., & Goodkin, M. L. (2020). Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil. Clinical Therapeutics, 42( 2), 263-275. doi:10.1016/j.clinthera.2019.12.008
    • NLM

      Belfort Junior R, Paula JS, Silva MJL, Della Paolera M, Kim T, Chen MY, Goodkin ML. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil [Internet]. Clinical Therapeutics. 2020 ; 42( 2): 263-275.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2019.12.008
    • Vancouver

      Belfort Junior R, Paula JS, Silva MJL, Della Paolera M, Kim T, Chen MY, Goodkin ML. Fixed-combination bimatoprost/brimonidine/timolol in glaucom: a randomized, masked, controlled, phase III study conducted in Brazil [Internet]. Clinical Therapeutics. 2020 ; 42( 2): 263-275.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2019.12.008
  • Fonte: Clinical Therapeutics. Unidade: FCFRP

    Assuntos: SEGURANÇA DO PACIENTE, FÁRMACOS, FARMACOVIGILÂNCIA, MEDICAMENTO

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VARALLO, Fabiana Rossi et al. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication. Clinical Therapeutics, v. 41, n. 3, p. 598-603, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2019.01.013. Acesso em: 27 jun. 2025.
    • APA

      Varallo, F. R., Forgerini, M., Herdeiro, M. T. F., & Mastroianni, P. de C. (2019). Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication. Clinical Therapeutics, 41( 3), 598-603. doi:10.1016/j.clinthera.2019.01.013
    • NLM

      Varallo FR, Forgerini M, Herdeiro MTF, Mastroianni P de C. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication [Internet]. Clinical Therapeutics. 2019 ; 41( 3): 598-603.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2019.01.013
    • Vancouver

      Varallo FR, Forgerini M, Herdeiro MTF, Mastroianni P de C. Harmonization of pharmacovigilance regulation in Brazil: opportunities to improve risk communication [Internet]. Clinical Therapeutics. 2019 ; 41( 3): 598-603.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2019.01.013
  • Fonte: Clinical Therapeutics. Unidades: FCF, FM

    Assuntos: ANTIBIÓTICOS, DOENÇAS INFECCIOSAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACHADO, Anna Silva et al. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients. Clinical Therapeutics, v. 39, n. 8, p. 1649-1657, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2017.06.008. Acesso em: 27 jun. 2025.
    • APA

      Machado, A. S., Oliveira, M. S., Sanches, C., Silva Junior, C. V. da, Gomez, D. S., Gemperli, R., et al. (2017). Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients. Clinical Therapeutics, 39( 8), 1649-1657. doi:10.1016/j.clinthera.2017.06.008
    • NLM

      Machado AS, Oliveira MS, Sanches C, Silva Junior CV da, Gomez DS, Gemperli R, Santos SRCJ, Levin ASS. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients [Internet]. Clinical Therapeutics. 2017 ; 39( 8): 1649-1657.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2017.06.008
    • Vancouver

      Machado AS, Oliveira MS, Sanches C, Silva Junior CV da, Gomez DS, Gemperli R, Santos SRCJ, Levin ASS. Clinical outcome and antimicrobial therapeutic drug monitoring for the treatment of infections in acute burn patients [Internet]. Clinical Therapeutics. 2017 ; 39( 8): 1649-1657.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2017.06.008
  • Fonte: Clinical Therapeutics. Unidade: FCF

    Assuntos: BIOEQUIVALÊNCIA, ZIDOVUDINA (FARMACOCINÉTICA)

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SERRA, Cristina Helena dos Reis et al. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study. Clinical Therapeutics, v. 30, n. 5, p. 902-908, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2008.05.003. Acesso em: 27 jun. 2025.
    • APA

      Serra, C. H. dos R., Koono, E. E. M., Kano, E. K., Schramm, S. G., Armando, Y. P., & Porta, V. (2008). Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study. Clinical Therapeutics, 30( 5), 902-908. doi:10.1016/j.clinthera.2008.05.003
    • NLM

      Serra CH dos R, Koono EEM, Kano EK, Schramm SG, Armando YP, Porta V. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study [Internet]. Clinical Therapeutics. 2008 ;30( 5): 902-908.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2008.05.003
    • Vancouver

      Serra CH dos R, Koono EEM, Kano EK, Schramm SG, Armando YP, Porta V. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study [Internet]. Clinical Therapeutics. 2008 ;30( 5): 902-908.[citado 2025 jun. 27 ] Available from: https://doi.org/10.1016/j.clinthera.2008.05.003

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025